Tech Company Inital Public Offerings
Adamas Pharmaceuticals IPO
Adamas Pharmaceuticals was bought by . Shares became public on 4/10/2014.
Transaction Overview
Company Name
Announced On
4/10/2014
Transaction Type
IPO
Amount
$48,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1900 Powell St. 750
Emeryville, CA 94608
USA
Emeryville, CA 94608
USA
Phone
Website
Email Address
Overview
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Went
Chief Financial Officer
Alfred Merriweather
Chief Financial Officer
Christopher Prentiss
Chief Medical Officer
Rajiv Patni
VP - Bus. Development
Sarah Mathieson
VP - Bus. Development
Vijay Shreedhar
VP - General Counsel
Jennifer Rhodes
Browse more venture capital transactions:
Prev: 4/10/2014: Munchery venture capital transaction
Next: 4/10/2014: Xolve venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs